Natarajan Sethuraman Sells 1,000 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) insider Natarajan Sethuraman sold 1,000 shares of Entrada Therapeutics stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $15.00, for a total transaction of $15,000.00. Following the completion of the transaction, the insider now owns 208,032 shares […]

Related Keywords

New York ,United States ,Natarajan Sethuraman ,Securities Exchange Commission ,Sg Americas Securities ,Nasdaq ,Tower Research Capital ,Acadian Asset Management ,Allspring Global Investments Holdings ,Entrada Therapeutics Inc ,Entrada Therapeutics ,Get Free Report ,Exchange Commission ,York State Teachers Retirement System ,Global Investments Holdings ,Asset Management ,Research Capital ,Entrada Therapeutics Daily ,